AI Advancements From FreeStyle Libre, Dexcom Take Center Stage at CES 2026
Healthcare Brew
|
Contributed by: Kate Gamble
Summary
The CES 2026 showcased significant advancements in AI-powered health technology, reflecting a growing trend among healthcare professionals to integrate artificial intelligence into patient care and medical devices. Notable innovations included Abbott's AI-enhanced FreeStyle Libre system for glucose monitoring and Dexcom's app providing AI-driven advice for diabetes management. Additionally, the Ukrainian startup .lumen introduced AI-assisted glasses for the visually impaired, winning recognition for innovations in accessibility. These developments highlight the potential of AI to transform patient care and accessibility in healthcare settings, emphasizing the need for ongoing adaptation and investment in these technologies.
